HomeNewsBusinessEarningsParabolic Drugs standalone Sep '13 sales at Rs 117.12 crore

Parabolic Drugs standalone Sep '13 sales at Rs 117.12 crore

Parabolic Drugs has reported a standalone sales turnover of Rs 117.12 crore and a net loss of Rs 22.32 crore for the quarter ended Sep '13

November 18, 2013 / 16:39 IST
Story continues below Advertisement

Parabolic Drugs has reported a standalone sales turnover of Rs 117.12 crore and a net loss of Rs 22.32 crore for the quarter ended Sep '13.
For the quarter ended Sep 2012 the standalone sales turnover was Rs 251.65 crore and net loss was Rs 25.25 crore.
Parabolic Drugs shares closed at 5.45 on November 14, 2013 (NSE) and has given -18.66% returns over the last 6 months and -59.33% over the last 12 months.
Parabolic Drugs
Standalone Quarterly Results-------- in Rs. Cr. --------
Sep '13Jun '13Mar '13
Sales Turnover117.1299.4857.57
Other Income------
Total Income117.1299.4857.57
Total Expenses112.8597.09180.93
Operating Profit4.272.39-123.36
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses--10.70--
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit4.272.39-123.36
Interest19.5920.0016.71
PBDT-15.32-6.91-140.07
Depreciation16.9917.0415.93
Depreciation On Revaluation Of Assets------
PBT-32.31-23.95-156.00
Tax-9.99---57.33
Net Profit-22.32-23.95-98.67
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share------
Book Value------
Equity61.8961.8961.89
Reserves------
Face Value10.0010.0010.00
Source : Dion Global Solutions Limited
first published: Nov 18, 2013 04:39 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!